Central Nervous System Pharmacology Practice Questions

Q: In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?

Prilocaine. **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.** ***Prilocaine*** - **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**. - It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**. *Cocaine* - **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**. - Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**. *Procaine* - **Procaine** is a classic **ester-type local anesthetic** (an aminoester). - An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification. *Tetracaine* - **Tetracaine** is also an **ester-type local anesthetic** (an aminoester). - It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.

Q: Which anaesthetic belongs to the ester group?

Procaine. ***Procaine*** - **Procaine** is a classical **ester-type** local anesthetic, characterized by an ester linkage between the aromatic and amine parts of its chemical structure. - Ester-type local anesthetics are metabolized by **plasma pseudocholinesterase**, leading to a shorter duration of action compared to amides. *Benzocaine* - **Benzocaine** is also an ester local anesthetic, but it is typically used topically due to its poor water solubility and absorption. - While an ester, the question implies a common injectable agent, making procaine a more representative answer for the "ester group" in general anesthetic use. *Lignocaine* - **Lignocaine** (also known as lidocaine) is an **amide-type** local anesthetic, which can be identified by an amide linkage in its chemical structure. - Amide local anesthetics are primarily metabolized in the **liver** and generally have a longer duration of action than esters. *Propofol* - **Propofol** is a **short-acting intravenous general anesthetic** and is not classified as a local anesthetic or belonging to the ester group. - It works by potentiation of **GABA-A receptors** and is used for induction and maintenance of general anesthesia.

Q: What is the drug of choice for managing generalized tonic-clonic seizures (GTCS) during pregnancy?

Lamotrigine. ***Lamotrigine*** - **Lamotrigine** is considered **one of the preferred drugs** for managing epilepsy during pregnancy due to its relatively **low teratogenic risk** compared to older antiepileptic drugs. - Its established safety profile in pregnancy makes it a preferred option to balance seizure control and **fetal well-being**. - **Important Note:** For **GTCS specifically**, lamotrigine and levetiracetam are both considered appropriate first-line choices, with selection depending on individual patient factors and seizure control history. - Lamotrigine levels **decrease during pregnancy** and require monitoring and dose adjustments. *CBZ* - **Carbamazepine (CBZ)** is associated with an increased risk of **neural tube defects** and other congenital malformations when used during pregnancy, making it less favorable. - While effective for GTCS, its teratogenicity often leads to avoidance or careful consideration of alternatives in pregnant women. *Levetiracetam* - **Levetiracetam** is increasingly recognized as an **excellent choice for GTCS in pregnancy** with a favorable safety profile and growing evidence base. - Many recent guidelines and clinical practices favor levetiracetam as **first-line for GTCS** due to its low risk of major congenital malformations and good efficacy. - It is a **medically appropriate alternative** to lamotrigine, and in some contexts may be preferred, particularly for primary generalized epilepsy. *Valproate* - **Valproate** has the highest risk of **teratogenicity** among common antiepileptic drugs, including a significant risk of **neural tube defects**, developmental delay, autism spectrum disorder, and other anomalies. - Due to these significant risks, valproate is generally **contraindicated** in women of childbearing potential, especially during pregnancy, unless no other effective and safer alternative exists.

Q: Which of the following statements about lamotrigine is correct?

Has a half-life of approximately 24 hours.. ***Has a half-life of approximately 24 hours.*** - Lamotrigine's **half-life** is typically around **24 to 33 hours** in adults, which allows for once or twice-daily dosing. - This relatively long half-life is advantageous for maintaining **stable plasma concentrations** and improving patient adherence. *Is the first choice for absence seizures.* - **Ethosuximide** or **valproate** are generally considered first-line treatments for **absence seizures**. - Lamotrigine is not the preferred initial therapy due to its **slower titration** and occasional lack of efficacy in this seizure type. *Is not significantly metabolized in the liver.* - Lamotrigine is **significantly metabolized** in the liver, primarily through **glucuronidation** by the **UGT1A4 enzyme**. - This hepatic metabolism explains many of its **drug interactions**, particularly with other antiepileptic drugs affecting UGT enzymes. *Has decreased efficacy in treating depressive episodes.* - Lamotrigine is known for its **mood-stabilizing properties** and is effective in treating and preventing **depressive episodes**, particularly in **bipolar disorder**. - Its efficacy in depression is a key distinguishing feature, making it a valuable option for patients with comorbid mood disorders.

Q: Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Vigabatrin. ***Vigabatrin*** - **Vigabatrin** is known to cause **irreversible concentric visual field constriction** (peripheral vision loss) due to retinal toxicity. - Regular **ophthalmological monitoring**, including **visual field testing**, is crucial before and during treatment to detect and manage this adverse effect early. *Topiramate* - Topiramate can cause **acute angle-closure glaucoma** and **myopia**, which affect vision, but regular visual field monitoring is not a primary requirement for this specific side effect. - Its main concerns often relate to cognitive side effects and kidney stones, rather than progressive visual field loss requiring baseline and ongoing field testing. *Valproic acid* - Valproic acid is not typically associated with specific visual field defects requiring routine monitoring. - Its major side effects often involve **hepatotoxicity**, **pancreatitis**, and **teratogenicity**. *Carbamazepine* - Carbamazepine's notable side effects include **aplastic anemia**, **hyponatremia**, and **Stevens-Johnson syndrome**. - While it can cause some ocular side effects like **diplopia** or **nystagmus**, it does not typically lead to the progressive and irreversible visual field constriction seen with vigabatrin, which necessitates strict monitoring.

Q: Which of the following is NOT typically produced by local anesthetics?

Dysphoria. Detailed Analysis: ***Dysphoria*** - While local anesthetics can cause a range of central nervous system effects with toxicity, **dysphoria** (a state of unease or generalized dissatisfaction with life) is not a typical or primary direct effect of their action on receptors. High doses or systemic absorption might lead to anxiety and restlessness, but dysphoria specifically is uncommon. - The primary mechanism of local anesthetics involves blocking **voltage-gated sodium channels** [1], leading to a reversible loss of sensation, not directly causing mood disturbances like dysphoria. *Euphoria* - **Euphoria** can sometimes be observed with systemic local anesthetic toxicity due to initial CNS stimulation before depression. Some individuals report a transient feeling of well-being or altered mental status with high systemic levels of certain local anesthetics. - This effect is not a direct therapeutic goal but rather an **adverse reaction** associated with systemic absorption and CNS excitation. *Analgesia* - **Analgesia** is the primary therapeutic effect of local anesthetics, achieved by blocking nerve impulse transmission. This prevents the sensation of pain from reaching the brain [1]. - They work by **blocking sodium channels** in nerve membranes [1], thereby inhibiting the initiation and propagation of action potentials [2]. *Muscle relaxation* - **Muscle relaxation** in the area of blockade is a direct consequence of the local anesthetic's action on the motor nerves supplying the muscles. - By blocking nerve conduction in **motor nerve fibers** [1], local anesthetics prevent muscle contraction, leading to temporary skeletal muscle paralysis.

Q: What serious side effect may lead to the discontinuation of felbamate?

Aplastic anemia. ***Aplastic anemia*** - Felbamate is known to cause **aplastic anemia**, a severe and life-threatening condition where the **bone marrow stops producing enough new blood cells**. - Felbamate carries a **black box warning** for both aplastic anemia and **hepatotoxicity (severe liver failure)**, which are the two most serious adverse effects leading to discontinuation. - Due to this significant risk, felbamate is reserved for severe, refractory epilepsy cases, and patients require **regular monitoring** of blood counts and liver function tests. *Renal impairment* - While some medications can cause renal impairment, **felbamate is not primarily associated** with this side effect to the extent of requiring discontinuation. - Its metabolism and excretion are predominantly **hepatic (liver)**, and renal effects are less common or severe. *Gastrointestinal disorder* - Gastrointestinal side effects like nausea or vomiting are **common with many medications**, including felbamate, but are generally **mild and manageable**, rarely leading to discontinuation. - These effects are usually **dose-dependent** and can often be mitigated with supportive care. *Seizures* - Felbamate is an **antiepileptic drug (AED)**, so it is used to treat seizures, not cause them. - If a patient experiences seizures while on felbamate, it usually indicates **inadequate treatment response** or seizure exacerbation, rather than a direct side effect necessitating discontinuation for toxicity.

Q: Which is a GABA transaminase inhibitor?

Valproate. ***Valproate*** - Valproate is known to inhibit **GABA transaminase**, an enzyme responsible for the breakdown of **gamma-aminobutyric acid (GABA)**. - By inhibiting this enzyme, valproate increases the concentration of **GABA** in the brain, enhancing its inhibitory effects and contributing to its anticonvulsant properties. *TCA* - **Tricyclic antidepressants (TCAs)** primarily work by inhibiting the reuptake of **norepinephrine** and **serotonin** in the brain. - They do not directly inhibit GABA transaminase but rather modulate monoamine neurotransmission. *Sertraline* - **Sertraline** is a **selective serotonin reuptake inhibitor (SSRI)** that works by blocking the reabsorption of **serotonin** into presynaptic neurons. - Its primary mechanism of action is focused on serotonin pathways, not on GABA metabolism. *Gabapentin* - **Gabapentin** is an anticonvulsant that is thought to exert its effects by modulating **calcium channels** and increasing **GABA synthesis**, but it is not a direct inhibitor of GABA transaminase. - Its mechanism of action is distinct from directly preventing GABA breakdown.

Q: Which dopamine receptor is known for its inhibitory action in the central nervous system?

Dopamine Receptor D2. ***Dopamine Receptor D2*** - The **D2 receptor** is a member of the D2-like family (D2, D3, D4), which are **G-protein coupled receptors** that inhibit adenylyl cyclase activity. - Its activation typically leads to a **decrease in neuronal excitability** and neurotransmitter release, providing an inhibitory effect in the CNS. *Dopamine Receptor D5* - The **D5 receptor** belongs to the D1-like family (D1, D5), which are **G-protein coupled receptors** that stimulate adenylyl cyclase activity. - Activation of D5 receptors typically leads to **excitatory effects** rather than inhibitory ones in the CNS. *No inhibitory dopamine receptor present* - This statement is incorrect as specific dopamine receptor subtypes, particularly the **D2-like family**, are well-established to exert inhibitory actions in the CNS. - These inhibitory effects are crucial for various physiological processes, including motor control and reward pathways. *Dopamine Receptor D1* - The **D1 receptor** is part of the D1-like family (D1, D5) and is known for its **excitatory effects** in the CNS. - Activation of D1 receptors leads to an **increase in intracellular cAMP** and generally enhances neuronal activity.

Q: Which of the following is not an ionic receptor?

mGluR. **Ionic receptors** (ionotropic receptors) are ligand-gated ion channels that open upon binding, allowing ions to flow directly through the channel. **Non-ionic receptors** (metabotropic receptors) are G-protein coupled receptors that activate intracellular signaling cascades. ***mGluR*** - **Metabotropic glutamate receptors (mGluRs)** are **G-protein coupled receptors** (GPCRs), meaning they activate intracellular signaling pathways rather than directly forming an ion channel. - Their activation leads to slower, longer-lasting changes in neuronal excitability through second messenger systems. - **This is the correct answer** as mGluRs are NOT ionic receptors. *NMDA* - **NMDA receptors** are **ionotropic glutamate receptors** that form ligand-gated ion channels permeable to calcium and sodium ions. - They are crucial for **synaptic plasticity** and learning. *Kainate* - **Kainate receptors** are also **ionotropic glutamate receptors** that are permeable to sodium and potassium ions. - They play diverse roles in synaptic transmission and neuronal excitability. *AMPA* - **AMPA receptors** are **ionotropic glutamate receptors** primarily responsible for fast excitatory synaptic transmission in the central nervous system. - They are permeable to sodium and potassium ions and mediate the majority of fast excitatory synaptic currents.

Question 1

In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?

Accepted Answer

Prilocaine

Answer

Procaine

Answer

Cocaine

Answer

Tetracaine

Question 2

Which anaesthetic belongs to the ester group?

Accepted Answer

Procaine

Answer

Lignocaine

Answer

Propofol

Answer

Benzocaine

Question 3

What is the drug of choice for managing generalized tonic-clonic seizures (GTCS) during pregnancy?

Accepted Answer

Lamotrigine

Answer

CBZ

Answer

Levetiracetam

Answer

Valproate

Question 4

Which of the following statements about lamotrigine is correct?

Accepted Answer

Has a half-life of approximately 24 hours.

Answer

Is the first choice for absence seizures.

Answer

Is not significantly metabolized in the liver.

Answer

Has decreased efficacy in treating depressive episodes.

Question 5

Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Accepted Answer

Vigabatrin

Answer

Topiramate

Answer

Valproic acid

Answer

Carbamazepine

Question 6

Which of the following is NOT typically produced by local anesthetics?

Accepted Answer

Dysphoria

Answer

Muscle relaxation

Answer

Euphoria

Answer

Analgesia

Question 7

What serious side effect may lead to the discontinuation of felbamate?

Accepted Answer

Aplastic anemia

Answer

Seizures

Answer

Renal impairment

Answer

Gastrointestinal disorder

Question 8

Which is a GABA transaminase inhibitor?

Accepted Answer

Valproate

Answer

TCA

Answer

Gabapentin

Answer

Sertraline

Question 9

Which dopamine receptor is known for its inhibitory action in the central nervous system?

Accepted Answer

Dopamine Receptor D2

Answer

Dopamine Receptor D5

Answer

No inhibitory dopamine receptor present

Answer

Dopamine Receptor D1

Question 10

Which of the following is not an ionic receptor?

Accepted Answer

mGluR

Answer

Kainate

Answer

AMPA

Answer

NMDA

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?